Log In
BCIQ
Print this Print this
 

HuATN-658 (Hu-ATN-658)

  Manage Alerts
Collapse Summary General Information
Company Monopar Therapeutics LLC
DescriptionHuman mAb targeting plasminogen activator urokinase receptor (PLAUR; uPAR; suPAR)
Molecular Target Plasminogen activator urokinase receptor (PLAUR) (uPAR) (suPAR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation
PartnerCancer Research UK

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

07/09/2015

0

0

0

Get a free BioCentury trial today